$HALO
Price history, market instrument context, member research, and related headlines in one place.
HALO key statistics
NasdaqGSUSD
52-week range
$61.2399%$122.33
Latest session $117.38–$122.33Halozyme Therapeutics, Inc. (HALO) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $121.51, up $4.69 (4.01%) from the previous close of $116.82. It has traded between $117.38 and $122.33 in the latest session. Over the past year it has ranged from $61.23 to $122.33, leaving it trading at the top of its 52-week range. Reported volume for the session was 2.5M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Halozyme CEO Helen Torley sells $6.28m in company shares — See source for full details.
Halozyme Therapeutics stock hits all-time high of 104.86 USD — See source for full details.
Halozyme projects 2026 non-GAAP EPS of $8.65-$9.00 while raising revenue outlook to $1.835B-$1.91B — See source for full details.
Loading $HALO research…